MediciNova Inc (MNOV)
2.075
+0.08
(+3.75%)
USD |
NASDAQ |
Nov 22, 13:35
MediciNova Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.00M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | 0.0375M |
| June 30, 2021 | |
| March 31, 2021 | 4.00M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 6.00M |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | 0.0033M |
| December 31, 2012 | 0.034M |
| September 30, 2012 | 0.0838M |
| June 30, 2012 | 0.4936M |
| March 31, 2012 | 0.1912M |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0375M
Minimum
Sep 2021
4.00M
Maximum
Mar 2021
1.679M
Average
1.00M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| BioVie Inc | -- |
| BridgeBio Pharma Inc | 2.732M |
| Ikena Oncology Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.628M |
| Total Expenses (Quarterly) | 3.046M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 53.75M |
| Earnings Yield | -7.71% |
| Normalized Earnings Yield | -9.157 |